Clinical TrialsSearch results
Number of results: 225
Other
- Randomized comparative study of cisplatin, docetaxel, and irinotecan versus cisplatin and docetaxel in patients with stage IIIB or stage IV non-small cell lung cancer (OLCSG 0403)
- Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-13
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Other
- Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia
- acute myelocytic leukemia
- Japan Adult Leukemia Study Group
- 2005-09-20
Other
- Prospective Study of hyperphosphatemia in CKD5D patients undergoing hemodialysis (STOP-HD).
- Hemodialysis patients with hyperphosphatemia
- Phosphate Research group
- 2009-05-25
Other
- Prospective Observational Survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome
- Refractory (drug resistant) nephrotic syndrome
- the Japanese Society of Kidney and Lipids Research
- 2007-11-01
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- preoperative combined chemothrapy with docetaxel, cisplatin and S-1 in local advanced gastric cancer; multicentric phase II study
- local advanced gastric cancer (excluding T3-4, bulky N2 & N3 and giant type3 & type 4)
- Society for the study of DCS therapy
- 2009-07-01
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19